Since our first automated cellular processing system, the AXP­® System, released in 2006, ThermoGenesis Holdings has been a market leader in the development and commercialization of automated and semi-automated technologies to provide the sensitivity as well as the flexibility necessary to meet the needs of a broad base of cell processing applications.

AXP® II System

A closed automated sterile system that consistently and efficiently processes the stem cell-rich buffy coat from umbilical cord blood. The system reduces a unit of cord blood to a user defined end volume with precision, safety and confidence.

X-LAB® System

A density media free, semi-automated closed processing system for the rapid isolation and enrichment of cells from blood and blood products.